124 / 1084
Oesophageal Cancer – CROSS Study
RCTX +
Surgery
Surgery
alone
Hospital mortality
4%
4%
R0 Resection
92%
69%
© Universitätsmedizin Leipzig: University Cancer Center Leipzig (UCCL), Prof. Dr. F. Lordick
Van Hagen et al.
N Engl J Med
2012; 366: 2074-2084
pCR rate
29%
Median survival
49.4 months
24 months
HR 0.657
p = 0.003
5-year-survival
47%
34%